Linking Cardiovascular Risk With Estradiol Level in Men

Aim      To study the relationship between the cardiovascular risk and the level of estradiol in men of young and middle age. The main group included 71 patients with newly diagnosed hyperestrogenia (HE) (serum estradiol >41.2 pg/ ml). Using pseudorandomization, 68 men with normal estradiol level and age- and body weight index (BWI)-matched with the main group were included into the control group. Anthropometric data, bioimpedance variables, blood pressure (BP), and concentrations of estradiol, testosterone, glucose, and total cholesterol were analyzed in both groups.

Results Patients of the main and control groups did not differ in age, BWI, and smoking status. Testosterone concentration was 10.18 nmol/l in the HE group and 12.18 nmol /l in the control group (p=0.006). Systolic BP was 142.0 mm Hg in the HE group and 135.2 mm Hg in the control group (p=0.011); diastolic BP was 90.3 mm Hg in the HE group and 86.2 mm Hg in the control group (p=0.008). Total cholesterol was 5.87 mmol/l in the HE group and 5.33 mmol/l in the control group (p=0.023). Blood glucose did not differ between the groups. The presence of HE in men 2.11 times (р=0.038) increased the probability of arterial hypertension. The intergroup difference by the SCORE scale did not reach statistical significance (р=0.172). BWI, waist and hip circumferences, and bioimpedance body composition parameters did not differ between the groups.

Conclusion      In the studied cohort of young and middle-aged men, HE was an independent predictor for the presence of arterial hypertension. There were no significant intergroup differences in the total risk of cardiovascular diseases calculated with the SCORE scale.

1. Lu Y, Pechlaner R, Cai J, Yuan H, Huang Z, Yang G et al. Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. Journal of the American College of Cardiology. 2020;75(8):870–80. DOI: 10.1016/j.jacc.2019.12.039

2. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10):3007–19. DOI: 10.1210/jc.2011-1137

3. Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences. 2017;8(1):33. DOI: 10.1186/s13293-017-0152-8

4. Sudhir K, Komesaroff PA. Cardiovascular Actions of Estrogens in Men. The Journal of Clinical Endocrinology & Metabolism. 1999;84(10):3411–5. DOI: 10.1210/jcem.84.10.5954

5. Lerchbaum E, Pilz S, Grammer T, Boehm B, März W, Obermayer-Pietsch B. High Estradiol Levels are Associated with Increased Mortality in Older Men Referred to Coronary Angiography. Experimental and Clinical Endocrinology & Diabetes. 2011;119(8):490–6. DOI: 10.1055/s-0031-1284370

6. Cigankova O.V., Nikolaev K.Yu., Fedorova E.L., Bondareva Z.G. Sex hormones metabolism in men through the prism of cardiovascular risk. Journal of Atherosclerosis and Dyslipidemias. 2014;1(14):17–24.

7. Narayanan K, Havmoeller R, Reinier K, Jerger K, Teodorescu C, Uy-Evanado A et al. Sex hormone levels in patients with sudden cardiac arrest. Heart Rhythm. 2014;11(12):2267–72. DOI: 10.1016/j.hrthm.2014.08.031

8. The Coronary Drug Project. Initial Findings Leading to Modifications of Its Research Protocol. JAMA. 1970;214(7):1303–13. DOI: 10.1001/jama.1970.03180070069012

9. Kanakis GA, Nordkap L, Bang AK, Calogero AE, Bártfai G, Corona G et al. EAA clinical practice guidelines – gynecomastia evaluation and management. Andrology. 2019;7(6):778–93. DOI: 10.1111/andr.12636

10. Lv X, Jiang Y-T, Zhang X-Y, Li L-L, Zhang H-G, Liu R-Z. Associations of sex hormone levels with body mass index (BMI) in men: a cross-sectional study using quantile regression analysis. Asian Journal of Andrology. 2023;25(1):98–102. DOI: 10.4103/aja202212

11. Basu A, Seth S, Arora K, Verma M. Evaluating Estradiol Levels in Male Patients with Colorectal Carcinoma. Journal of clinical and diagnostic research. 2015;9(1):BC08-10. DOI: 10.7860/JCDR/2015/10508.5397

12. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS et al. Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth. Cancer Research. 2008;68(11):4447–54. DOI: 10.1158/0008-5472.CAN-08-0249

13. Mayo Clinic Laboratories. EEST - Overview: Estradiol, Serum. [Internet] Available at: https://www.mayocliniclabs.com/test-catalog/Overview/81816

14. Chadid S, Barber JR, Rohrmann S, Nelson WG, Yager JD, Kanarek NF et al. Age-Specific Serum Total and Free Estradiol Concentrations in Healthy Men in US Nationally Representative Samples. Journal of the Endocrine Society. 2019;3(10):1825–36. DOI: 10.1210/js.2019-00178

15. Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E et al. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). European Journal of Preventive Cardiology. 2019;26(14):1534–44. DOI: 10.1177/2047487319846715

16. Dedov I.I., Mokrysheva N.G., Melnichenko G.A., Rozhivanov R.V., Kamalov A.A., Mkrtumyan А.M. et al. Draft of Russian Clinical Practice Guidelines “Male hypogonadism”. Obesity and metabolism. 2022;18(4):496–507. DOI: 10.14341/omet12817

17. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. The American Journal of Medicine. 1983;74(5):863–9. DOI: 10.1016/0002-9343(83)91078-1

18. Ärnlöv J, Pencina MJ, Amin S, Nam B-H, Benjamin EJ, Murabito JM et al. Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men. Annals of Internal Medicine. 2006;145(3):176–84. DOI: 10.7326/0003-4819-145-3-200608010-00005

19. Wang C, Zhang W, Wang Y, Wan H, Chen Y, Xia F et al. Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study. Cardiovascular Diabetology. 2019;18(1):97. DOI: 10.1186/s12933-019-0901-6

20. Callou De Sá EQ, Feijó De Sá FC, E Silva RDS, De Oliveira KC, Guedes AD, Feres F et al. Endogenous oestradiol but not testosterone is related to coronary artery disease in men: Sex hormones and coronary artery disease. Clinical Endocrinology. 2011;75(2):177–83. DOI: 10.1111/j.1365-2265.2011.04017.x

21. Collet T-H, Ewing SK, Ensrud KE, Laughlin GA, Hoffman AR, Varosy PD et al. Endogenous Testosterone Levels and the Risk of Incident Cardiovascular Events in Elderly Men: The MrOS Prospective Study. Journal of the Endocrine Society. 2020;4(5):bvaa038. DOI: 10.1210/jendso/bvaa038

22. Aribas E, Ahmadizar F, Mutlu U, Ikram MK, Bos D, Laven JSE et al. Sex steroids and markers of micro- and macrovascular damage among women and men from the general population. European Journal of Preventive Cardiology. 2022;29(9):1322–30. DOI: 10.1093/eurjpc/zwaa031

23. Chakrabarti S, Lekontseva O, Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life. 2008;60(6):376–82. DOI: 10.1002/iub.48

24. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine. 2016;374(13):1221–31. DOI: 10.1056/NEJMoa1505241

25. Taylor LE, Sullivan JC. Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2016;311(4):R714–20. DOI: 10.1152/ajpregu.00202.2016

26. Stachenfeld NS, Keefe DL. Estrogen effects on osmotic regulation of AVP and fluid balance. American Journal of Physiology-Endocrinology and Metabolism. 2002;283(4):E711–21. DOI: 10.1152/ajpendo.00192.2002

27. Milner TA, Contoreggi NH, Yu F, Johnson MA, Wang G, Woods C et al. Estrogen Receptor β Contributes to Both Hypertension and Hypothalamic Plasticity in a Mouse Model of Peri-Menopause. The Journal of Neuroscience. 2021;41(24):5190–205. DOI: 10.1523/JNEUROSCI.0164-21.2021

28. Liu PY, Christian RC, Ruan M, Miller VM, Fitzpatrick LA. Correlating Androgen and Estrogen Steroid Receptor Expression with Coronary Calcification and Atherosclerosis in Men without Known Coronary Artery Disease. The Journal of Clinical Endocrinology & Metabolism. 2005;90(2):1041–6. DOI: 10.1210/jc.2004-1211

29. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. New England Journal of Medicine. 1997;336(14):973–9. DOI: 10.1056/NEJM199704033361401

30. Pour HRN, Grobbee DE, Muller M, Van Der Schouw YT. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clinical Endocrinology. 2007;66(3):394–8. DOI: 10.1111/j.1365-2265.2007.02745.x

31. Seli E, Guzeloglu-Kayisli O, Cakmak H, Kayisli UA, Selam B, Arici A. Estradiol Increases Apoptosis in Human Coronary Artery Endothelial Cells by Up-Regulating Fas and Fas Ligand Expression. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4995–5001. DOI: 10.1210/jc.2006-1225

32. Wranicz JK, Cygankiewicz I, Kula P, Walczak-Jedrzejowska R, Slowikowska-Hilczer J, Kula K. Endogenous Estradiol and Testosterone may Predispose toward Atherogenic Lipid Profile, but Higher Blood Level of Testosterone is Associated with Lower Number of Stenoses in the Coronary Arteries of Men with Coronary Disease. International journal of biomedical science: IJBS. 2006;2(2):135–42. PMID: 23674975

33. Palmisano BT, Zhu L, Stafford JM. Role of Estrogens in the Regulation of Liver Lipid Metabolism. Advances in Experimental Medicine and Biology. 2017;1043:227–56. DOI: 10.1007/978-3-319-70178-3_12

34. Xue B, Johnson AK, Hay M. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2013;305(5):R459–63. DOI: 10.1152/ajpregu.00222.2013